Literature DB >> 3919031

Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.

K Takahashi, N Saijo, M Kimata, Y Sasaki, J Fujita, H Futami, E Shimizu, K Eguchi, T Shinkai, K Tominaga.   

Abstract

The achievable concentrations of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl-3-nitrosourea (ACNU), adriamycin, mitomycin C, vindesine, and epipodophyllotoxin suppressed the natural killer (NK) activity of human peripheral blood lymphocytes in vitro, whereas NK activity was not decreased 24 h after incubation with the maximum achievable concentration of cisplatin (cDDP). NK activity of patients treated with 80 mg per square meter of cDDP alone was not decreased for 3 weeks after cDDP administration. In contrast, NK activity of patients treated with the same dose of cDDP and methylprednisolone was significantly decreased 1 week after cDDP administration. It was concluded that methylprednisolone, used as an antiemetic agent, had an immunosuppressive effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919031     DOI: 10.1007/bf01884259

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  16 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 2.  Natural killer (NK) cells.

Authors:  R B Herberman
Journal:  Prog Clin Biol Res       Date:  1981

3.  Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice.

Authors:  P S Hochman; G Cudkowicz
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

4.  Effects of BCG and cyclophosphamide on the spontaneous and antibody-dependent cell-mediated cytotoxicity of peritoneal and spleen lymphocytes of ACI/N rats.

Authors:  N Saijo; N Irimajiri; A Ozaki; T Takizawa; Y Beppu; M Shibuya; E Shimizu
Journal:  Gan       Date:  1982-04

5.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

6.  Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon.

Authors:  N J Holbrook; W I Cox; H C Horner
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

7.  Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.

Authors:  N Saijo; A Ozaki; Y Beppu; K Takahashi; J Fujita; Y Sasaki; H Nomori; M Kimata; E Shimizu; A Hoshi
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

Authors:  R J Gralla; E S Casper; D P Kelsen; D W Braun; M E Dukeman; N Martini; C W Young; R B Golbey
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

Review 9.  Natural killer cells: their roles in defenses against disease.

Authors:  R B Herberman; J R Ortaldo
Journal:  Science       Date:  1981-10-02       Impact factor: 47.728

10.  Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

Authors:  N Saijo; E Shimizu; M Shibuya; N Irimajiri; T Takizawa; K Eguchi; T Shinkai; K Tominaga; Z Shimabukuro; T Taniguchi; A Hoshi
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

View more
  2 in total

1.  In vivo augmentation of the cytotoxicity of spleen lymphocytes against syngeneic B-16 melanoma cells and the suppression of the artificial metastases in C57BL/6 mice by subcutaneous multiple injections of high dose human recombinant interleukin-2 (rIL-2).

Authors:  N Saijo; A Ozaki; H Nakano; M Sakurai; H Takahashi; Y Sasaki; A Hoshi
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 2.  Hepatocellular carcinoma associated with lupoid hepatitis: a review of Japanese reports.

Authors:  T Sakaguchi; S Nakamura; S Suzuki; R Nishiyama; H Konno; S Baba; H Muro; T Kawasaki
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.